Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The German News Network.
Press releases published on July 23, 2025

BQR to Present 'Shift-Left Methodology for RAMS Analysis' ™ at European Symposium
Introducing a Game-Changing Approach to Electronics Design - BQR Unveils the Industry’s First Application of "Shift-Left Methodology to RAMS Analysis"™ RISHON LEZION, ISRAEL, July 23, 2025 /EINPresswire.com/ -- BQR Reliability Engineering Ltd., an …

Air Compressor Market to Reach $46.2 Billion by 2031 at 4.9% CAGR | Atlas Copco AB, Sulzer Ltd.
Air Compressor Market to Reach $46.2 Billion by 2031 at 4.9% CAGR | Atlas Copco AB, Sulzer Ltd. WILMINGTON, DE, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, “Air compressor market size by Type ( …

BAIA BIANCA SUITES TAKES CENTER STAGE THIS SUMMER ON ELBA ISLAND
The property reaffirms itself as a memorable destination for those seeking an authentic Mediterranean lifestyle experience MILAN, ITALY, July 23, 2025 /EINPresswire.com/ -- Baia Bianca Suites, the elegant luxury resort located in the exclusive setting …

Modern eLearning Market Opportunities with AI: The Role of Data in EdTech Solutions
The Role of Data in EdTech Solutions. How Agencies Like ColorWhistle Are Building Capabilities in LMS, Automation …

QAD Appoints Ken Fisher as President of Redzone to Drive Next Phase of Growth and Innovation
SANTA BARBARA, CA, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Fisher’s leadership will expand Redzone’s impact on manufacturing globally, advancing innovation and its mission to transform the industry by empowering the frontlines QAD Inc., the …

AI and Global Collaboration Take Center Stage at Newsmatics’ Prague Workshop
Global teams met to discuss advancing products such as EIN Presswire, Perspectify and the Newsmatics News Index during strategy workshops. WASHINGTON , DC, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Newsmatics, a leader in AI-powered news …

FinNewsAPI Unveils New Update to Empower Developers and Financial Institutions with Real-Time Global Market Insights
NEW YORK, NY, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- FinNewsAPI has officially launched a major update to its financial news API service, delivering faster, more accurate, and globally inclusive data to developers, fintech platforms, and …

67% of EU governmental institutions score D or F for cybersecurity efforts
VILNIUS, VILNIUS, LITHUANIA, July 23, 2025 /EINPresswire.com/ -- As recently as 2025, the European Commission announced new initiatives to promote cyber resilience and introduced legislation aimed at strengthening cybersecurity across the European Union …

Jobma Achieves ISO/IEC 27001 Certification, Reinforcing Secure and Privacy-First Hiring
This globally recognized ISO certification underscores Jobma’s commitment to data security, regulatory compliance, and protecting user privacy. MINNETONKA, MN, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Jobma, a leading AI video interviewing and …

Google Analytics Still Dominates (96.3%), But Tech Teams Look for Alternatives
TechBehemoths surveyed 830 companies across 34 countries to reveal which analytics tools they use beyond Google Analytics — and what’s next for GA in 2025 BERLIN, BERLIN, GERMANY, July 23, 2025 /EINPresswire.com/ -- TechBehemoths, a leading platform …

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
BERKELEY, Calif. and MAINZ, Germany, July 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company“), a diagnostics company specializing in the early detection of cancer, today announced a collaboration with CARE …

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock
The trial will evaluate safety, dosing, and efficacy in patients with cardiogenic shock Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial …